Compare Bio Protocol (BIO) vs Solana (SOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Solana — how do they compare? Bio Protocol trades at Rp440.06 (market cap Rp995,47M, Rp176,04M 24h volume), while Solana trades at Rp1,361,488 (market cap Rp790,85T, Rp21,56T 24h volume). The key difference: Solana is far larger — about 794448.9× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Solana's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Solana for 68 Days on average.
| BIO | SOL | |
|---|---|---|
Market Cap | Rp995,47M | Rp790,85T |
Volume (24h) | Rp176,04M | Rp21,56T |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 582,6M SOL |
Typical Hold Time | 18 Days | 68 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Solana is trading at Rp1,353,905 with a market cap of Rp789.03T, showing neutral technical signals overall. The asset is positioned between key support at Rp1,339,592 and resistance at Rp1,371,106, with oscillators neutral but moving averages leaning bearish. Recent ecosystem growth includes surpassing 31,000 unique wallets and 4 million SOL in assets under delegation, indicating steady network adoption despite the neutral technical outlook.
Overall outlook is cautiously neutral with opportunities in Solana's growing infrastructure and institutional adoption through liquid staking platforms. Major risks include typical crypto volatility, regulatory uncertainty, and competition from other layer-1 protocols. Investors should monitor key support levels and ecosystem developments for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Solana
SOL is the native token of Solana, an open source project which implements a new, high-performance, permission less blockchain. It is also the fastest blockchain in the world and the fastest growing ecosystem in crypto, with over 400 projects spanning DeFi, NFTs, Web3 and more. The architecture of their blockchain are build based on Proof of History (PoH); a proof for verifying order and passage of time between events.
Read more on SOL →
